McKesson Ventures is the corporate venture capital arm of McKesson Corporation that invests in healthcare technology and services companies across early to growth stages. Based in San Francisco, it seeks minority investments to support digital health and technology-enabled services that improve healthcare delivery for pharma, pharmacy, providers, and patients. The firm targets opportunities in healthcare information technology, health tech, and healthcare systems, with a focus on innovative direct-to-consumer health care and new clinical services, aiming to back ventures that enhance efficiency and care outcomes across the health care economy.
IVX Health is a leading provider of infusion and injection therapy for patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, and others. They operate private, comfortable clinics offering flexible scheduling, including evenings and weekends.
IVX Health
Series C in 2019
IVX Health is a leading provider of infusion and injection therapy for patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, and others. They operate private, comfortable clinics offering flexible scheduling, including evenings and weekends.
IVX Health
Series B in 2017
IVX Health is a leading provider of infusion and injection therapy for patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, and others. They operate private, comfortable clinics offering flexible scheduling, including evenings and weekends.
McQueary Brothers
Acquisition in 2008
McQueary Bros. Drug Company, a Springfield, Missouri–based regional distributor of pharmaceutical, health, and beauty products to more than 400 independent pharmacies in Missouri, Arkansas, Illinois, Kansas, Oklahoma, Nebraska, and Iowa.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.